--- Chain 8 for Question 158 ---
Status: PRUNED
Is Active Flag: False
Finish Reason: worker_terminated_unexpectedly
Reasoning Complete Flag: True
Error: None
Prompt Tokens: 210
Completion Tokens: 657
Completed Thoughts: 3
Pruned at Analysis Step: 5
Final Processed Boundaries: [0, 1158, 2152]

--- Full Content ---
Okay, so I have this question about transcription factors and mutations. Hmm, let me try to think it through. Alright, the question is about two different mutations and their effects on the transcription factor.

So, the transcription factor is normally inactive until it gets a signal. The signal comes from a phosphorylation cascade at the membrane. When the Ser residues in the transactivation domain get phosphorylated, the subunit dimerizes, moves to the nucleus, and helps with gene transcription.

Now, the first part says that mutation X in the transactivation domain is a recessive loss-of-function mutation. So, for that, you probably need both copies to be mutated to see the effect because it's recessive. So, in heterozygotes, the wild-type allele would compensate, but in homozygotes, both are broken, so no function.

But the question is about mutation Y in the dimerization domain. It's a dominant-negative mutation. Oh right, dominant-negative means that even if you have one copy of the mutated gene, it can interfere with the normal allele. So it's a gain-of-function mutation in a way because it messes up the normal protein's function.

Wait, so the dimerization domain is where the subunits come together. If mutation Y is dominant-negative, when the cell has one copy of Y and one wild type, the Y mutant might prevent the wild type from dimerizing properly. Let me think about how that works. So, if Y makes the dimerization domain not work, then when the mutant subunit tries to form a dimer with the wild type, the whole thing might not function correctly. Because if one part is messed up, the dimer can't form properly, so neither can activate the transcription.

So, the question is about the molecular phenotype when Y is present. Let's look at the options.

Option A: Change of protein conformation and gain-of-function. So, dominant-negative would not lead to gain, it's more blocking. So maybe not A.

Option B: Protein degradation and loss of wild-type. Hmm, dominant-negative usually doesn't cause degradation. It's more about disrupting function. So maybe B is not it.

Option C: Loss of dimerization and wild-type. Wait, but if dimerization is lost, then the factor can't function, so wouldn't that lead to loss of function? But the option says wild-type phenotype. No, that doesn't make sense. Maybe C is incorrect.

Option D: Protein aggregation and loss of function. Aggregation could happen if the mutant proteins form incorrect structures and clump together. If the dimerization is faulty, maybe the mutant proteins form aggregates, which impede their function. So if the proteins aggregate, they can't move to the nucleus and activate transcription. So the cells would have loss of function. That sounds plausible.

Wait, but what does the presence of Y mean? Y is dominant-negative; it inhibits the wild type. So in a heterozygote, the mutant Y would interfere with the normal allele's function. So the overall effect would be that the transcription factor can't dimerize properly, leading to no gene activation.

So, the molecular